Therapeutic Potential of Dopamine and Related Drugs as Anti-Inflammatories and Antioxidants in Neuronal and Non-Neuronal Pathologies
Cindy Bandala,
Noemi Cárdenas-Rodríguez,
Julieta Griselda Mendoza-Torreblanca,
Itzel Jatziri Contreras-García,
Valentín Martínez-López,
Teresita Rocio Cruz-Hernández,
Jazmín Carro-Rodríguez,
Marco Antonio Vargas-Hernández,
Iván Ignacio-Mejía,
Alfonso Alfaro-Rodriguez,
Eleazar Lara-Padilla
Affiliations
Cindy Bandala
Neurociencia Básica, Instituto Nacional de Rehabilitación LGII, Secretaría de Salud, Mexico City 14389, Mexico
Noemi Cárdenas-Rodríguez
Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico
Julieta Griselda Mendoza-Torreblanca
Laboratorio de Neurociencias, Subdirección de Medicina Experimental, Instituto Nacional de Pediatría, Mexico City 04530, Mexico
Itzel Jatziri Contreras-García
Laboratorio de Fisiología, Escuela Militar de Graduados de Sanidad, UDEFA, Mexico City 11200, Mexico
Valentín Martínez-López
Unidad de Ingeniería de Tejidos, Terapia Celular y Medicina Regenerativa, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico
Teresita Rocio Cruz-Hernández
Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico
Jazmín Carro-Rodríguez
Escuela de Biología Experimental, Unidad Iztapalapa, Universidad Autónoma Metropolitana, Mexico City 09340, Mexico
Marco Antonio Vargas-Hernández
Subdirección de Investigación, Escuela Militar de Graduados de Sanidad, Mexico City 11200, Mexico
Iván Ignacio-Mejía
Laboratorio de Medicina Traslacional, Escuela Militar de Graduados de Sanidad, Mexico City 11200, Mexico
Alfonso Alfaro-Rodriguez
Neurociencia Básica, Instituto Nacional de Rehabilitación LGII, Secretaría de Salud, Mexico City 14389, Mexico
Eleazar Lara-Padilla
Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico
Dopamine (DA), its derivatives, and dopaminergic drugs are compounds widely used in the management of diseases related to the nervous system. However, DA receptors have been identified in nonneuronal tissues, which has been related to their therapeutic potential in pathologies such as sepsis or septic shock, blood pressure, renal failure, diabetes, and obesity, among others. In addition, DA and dopaminergic drugs have shown anti-inflammatory and antioxidant properties in different kinds of cells. Aim: To compile the mechanism of action of DA and the main dopaminergic drugs and show the findings that support the therapeutic potential of these molecules for the treatment of neurological and non-neurological diseases considering their antioxidant and anti-inflammatory actions. Method: We performed a review article. An exhaustive search for information was carried out in specialized databases such as PubMed, PubChem, ProQuest, EBSCO, Scopus, Science Direct, Web of Science, Bookshelf, DrugBank, Livertox, and Clinical Trials. Results: We showed that DA and dopaminergic drugs have emerged for the management of neuronal and nonneuronal diseases with important therapeutic potential as anti-inflammatories and antioxidants. Conclusions: DA and DA derivatives can be an attractive treatment strategy and a promising approach to slowing the progression of disorders through repositioning.